Discussion
To our knowledge, this is the first study to assess the relationship between perioperative blood pressure parameters and visual or anatomic outcomes in diabetic patients undergoing vitrectomy. In our study population of patients with retinal traction or detachment, median 20-year duration of diabetes, and 80% prevalence of known systemic hypertension who underwent retinal detachment repair with 27g vitrectomy, the retina was attached in approximately 90% of cases and visual acuity improved by at least 3 Snellen lines in over 50% of patients by POM6. Seventy-five per cent of the cases were performed under MAC. Intraoperative increase in SBP ≥180 mm Hg was noted in nearly 50% of the cases, while clinically significant MAP ≤65 mm Hg was observed at least once in 20% of cases with nearly all requiring intraoperative vasopressor medications. Poor visual outcome (20/200 or worse vision) was more likely in patients with higher intraoperative SBP, DBP and MAP. Notably, patients with sustained SBP ≥180 mm Hg were nearly twice as likely to have visual acuity 20/200 or worse at POM6 compared with patients who did not have sustained SBP≥180 mm Hg. Patients with non-sustained SBP ≥180 mmHg were less likely to have three or more Snellen lines of improvement at POM6 than those without blood pressure elevation. Higher intraoperative variability in SBP was associated with worse measures of all visual outcomes studied.
The relationship between perioperative, and especially intraoperative, hypotension and poor surgical outcomes after cardiac and non-cardiac surgery has been well studied. Ischaemia and reperfusion injury secondary to systemic hypotension is believed to cause acute kidney injury, myocardial infarction, delirium and other end-organ damage.1–4 Despite this evidence, there are not guidelines establishing which blood pressure ranges constitute a hypotensive episode requiring intervention.1 In our study focusing on functional outcomes of vision in patients with baseline ischaemic diabetic disease, worse outcomes were actually observed in patients with higher intraoperative blood pressures. With the majority of patients in this study not having GA, the observed rate of systemic hypotension (MAP≤65) was relatively rare at 20% and nearly every case was treated intraoperatively. This may explain lack of significant association between low MAP and visual outcomes in our cohort.
The impact of systemic perioperative hypertension on adverse surgical outcomes is less established for both cardiac and non-cardiac surgery. There are many proposed mechanisms of action including increased inflammatory responses, reperfusion injury and platelet activation which may contribute to microvascular injury.13 14 However, the literature offers conflicting evidence as to whether intraoperative hypertension is a risk factor for poor surgical outcomes. Reich et al demonstrated that intraoperative hypertension was independently associated with adverse outcomes after major noncardiac surgery of long duration.5 Basali et al demonstrated that patients with postcraniotomy intracranial haemorrhage were more likely to have been hypertensive during the surgery.15 In contrast, Monk et al did not find intraoperative hypertension as a predictor for 30-day postoperative mortality following cardiac and non-cardiac surgery.3 This study found that greater intraoperative blood pressure was associated with worse visual outcomes at POM6. Nearly 30% of patients had sustained SBP ≥180 mm Hg and almost 80% of these patients had visual acuity 20/200 or worse at POM6, nearly double of 44% rate in patients without sustained blood pressure elevation. Only a small portion of those received antihypertensive therapy. While this management is in line with guidelines aiming to avoid intraoperative hypotony, further research is needed to establish an optimal approach to minimising prolonged intraoperative hypertensive periods especially in patients undergoing MAC, considering their lower risk of intraoperative hypotension as seen in this study.
Recently, the relationship between intraoperative blood pressure variability and poor surgical outcomes after cardiac and non-cardiac surgery has garnered a lot of interest. There are numerous ways to quantify blood pressure variability, with notable limitations to each metric. The SD, as chosen in this study, is widely used and allows for ease of interpretation,14 even though it does not incorporate variability between each subsequent measurement and is not robust to outliers.16 High variability may indicate haemodynamic instability while low variability may indicate the inability to adapt to haemodynamic changes.17 In a systematic review, Putowski et al found conflicting evidence that both high variability and low variability are associated with poor surgical outcomes.17 This study found that higher SD of intraoperative SBP had association with all analysed markers of worse visual outcomes, while MAP variability was only associated with lower probability of improvement in Snellen lines. Measures of blood pressure variability were more predictive of poor postoperative visual outcomes than mean intraoperative SBP, DBP and MAP. The strength of association between blood pressure variability and postoperative visual outcomes emphasises the importance of tight blood pressure control especially in patients undergoing GA who are more likely to have increased blood pressure variability.
Within the field of ophthalmology, Agarwal et al found that preprocedure blood pressure was not associated with adverse events during phacoemulsification,6 although cataract surgery is a much shorter procedure than the median tractional detachment repair duration of nearly 100 min seen in this study with lower requirement for anaesthetic medication use. Mahalingam et al found that high blood pressure was associated with delayed vitreous rebleed after vitrectomy while Ding et al and Matoda et al did not.7–9 Further, Suguira et al found an association between ophthalmodynamometric pressure, which assesses blood perfusion of the eye, and diastolic blood pressure.18
The patients with diabetic tractional detachments are significantly sicker than other ophthalmology patients with high prevalence of comorbidities as seen in this study. Diabetic vascular disease is characterised by significant pathologic changes to the microcirculation of the retina and kidneys and the macrocirculation. These vasculopathic changes secondary to increased angiogenic factors (VEGF and Ang-2) and hyperglycaemia may predispose patients to poor blood pressure control.19 20 The longer duration of tractional detachment repair, compared with other ophthalmological procedures, and resulting greater cumulative effects of intraoperative blood pressure parameters may have a more durable impact on patients’ visual outcomes. A 27g vitrectomy offers the opportunity to decrease duration of surgery and improve pain control, which may allow more patients to avoid GA, which accounted for only 25% of cases in this study.21 Lower anaesthetic requirement decreases the risk of intraoperative systemic hypotension in cases performed under MAC, which was seen in only 5.66% of cases who underwent MAC.22
There is conflicting evidence on the effect of fasting blood glucose on surgical outcomes after diabetic vitrectomy. Matoda et al and Mahalingam et al found an association between perioperative fasting blood glucose and vitreous haemorrhage but Ding et al did not.7–9 We did not find that perioperative fasting blood glucose was a statistically significant predictor for adverse visual or anatomical outcomes.
Our study is limited by the retrospective nature and is hypothesis-generating as there are no clear guidelines for perioperative blood pressure management that are outcomes evidence-driven in patients undergoing tractional diabetic detachment repair. The severity of baseline retinal disease and presence of vitreous haemorrhage in this study limited the ability to ascertain the degree of foveal non-perfusion at baseline. It is often difficult to determine precise duration of tractional diabetic retinal detachment due to its slow progressive nature and it is not as strongly correlated to visual outcomes as the severity of the detachment. The focus of this study was not to evaluate all determinates of visual loss in this population, but to use visual loss as a functional end-organ endpoint in evaluating perioperative blood pressure management. To minimise the effect of confounding variables, statistical analyses accounted for intrapatient clustering and baseline variables, including severity of preoperative retinal detachment and type of anaesthesia. Given that the data included two eyes from same patients, the intrapatient correlations derived from the GEE model highlight the need to account for within patient clustering. There are no universally agreed on measure of blood pressure variability and better measures than SD may be needed.16 In addition, recorded outcomes were limited to 6 months after surgery to focus on the short-term effects as use of long-term endpoints would confound the effect of perioperative variables by ongoing blood pressure control parameters in the outpatient setting. Even with this limitation, it is possible that the associations observed in this study may be reflective of or influenced by long-standing blood pressure effect on the vision with potential for greater blood pressure elevation and variability with surgical stress in patients with baseline poor blood pressure control.
We hope this study will highlight the effect of systemic hypertension on visual outcomes even in patients undergoing surgery under local anaesthesia with minimally invasive 27g PPV. Our findings may inform the design of future prospective studies incorporating more stringent blood pressure management, better data about blood pressure variables and control outside of the surgical setting, and individual data on the blood pressure response to intraoperative blood pressure control management.